Lubricious Medical Device Coatings Market Global Report 2026

The lubricious medical device coatings market size has grown strongly in recent years. It will grow from $1.83 billion in 2025 to $2 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing adoption of minimally invasive procedures, growing use of catheter-based medical devices, rising demand for improved device maneuverability, increasing focus on reducing procedure-related tissue trauma, and growing demand for enhanced patient comfort.

The lubricious medical device coatings market size is expected to see strong growth in the next few years. It will grow to $2.89 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. Growth over the forecast period is anticipated to be supported by increasing demand for advanced lubricious coatings for complex medical devices, wider adoption of next-generation hydrophilic coating technologies, growing need for longer-lasting coating performance, increasing use of lubricious coatings in advanced interventional procedures, and rising development of multifunctional medical device surfaces. Major trends during the forecast period include greater adoption of ultra-low-friction medical device coatings, increasing demand for durable lubricious coating formulations, wider use of hydrophilic coating technologies in minimally invasive devices, growing demand for coatings designed to reduce tissue trauma, and increasing development of biocompatible and highly lubricious surface treatments.

The increasing adoption of minimally invasive surgical procedures is expected to propel the growth of the lubricious medical device coatings market going forward. Minimally invasive surgical procedures are medical interventions performed through small incisions or natural body openings using specialized instruments and imaging technologies to minimize patient trauma, pain, and recovery time. The adoption of minimally invasive surgical procedures is increasing due to the rising prevalence of chronic diseases requiring interventional treatments, encouraging healthcare providers to prefer less invasive approaches with improved clinical outcomes. Lubricious medical device coatings support minimally invasive surgical procedures by reducing friction between medical devices and body tissues during insertion and navigation. They enhance device maneuverability, minimize tissue trauma, and improve procedural efficiency and patient comfort. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based professional medical organization, minimally invasive procedures increased by 7%, rising from 25.4 million procedures in 2022 to 27.2 million procedures in 2023. Therefore, the increasing adoption of minimally invasive surgical procedures is driving the growth of the lubricious medical device coatings market.

Major companies operating in the lubricious medical device coatings market are concentrating on developing advanced hydrophilic coating technologies that provide enhanced lubricity, durability, and biocompatibility for complex medical device applications. Hydrophilic coating technology creates low-friction surfaces while preserving coating integrity during device insertion, navigation, and withdrawal, thereby enhancing device performance during minimally invasive procedures. For instance, in October 2023, Surmodics Inc., a US-based medical device coating technology company, launched Preside hydrophilic coating technology, designed to deliver high lubricity and durability across a broader range of complex medical device applications. The technology complements Surmodics’ existing Serene hydrophilic coatings by providing a low-friction, low-particulate-generating surface that can improve distal access in neurovascular applications and facilitate device crossing in challenging coronary lesions and chronic total occlusions.

In November 2025, GTCR LLC, a US-based private equity firm, completed the acquisition of Surmodics Inc. for $627 million. The acquisition reinforces GTCR's position in the medical device coatings market by combining Surmodics' hydrophilic and other advanced coating technologies with Biocoat's existing coating capabilities, broadening its ability to support complex interventional medical device applications. Surmodics Inc. is a US-based medical device coating technology company.

Major companies operating in the lubricious medical device coatings market are Medtronic plc, Becton Dickinson and Company, DuPont de Nemours Inc, Teleflex Incorporated, Wacker Chemie AG, Cook Group Incorporated, The Lubrizol Corporation, Integer Holdings Corporation, Merit Medical Systems Inc, Freudenberg Medical LLC, Nordson Corporation, Koninklijke DSM N.V., Specialty Coating Systems Inc, Covalon Technologies Ltd, Precision Coating Company LLC, Biocoat Incorporated, Foster Corporation, Hydromer Inc, Harland Medical Systems Inc, AST Products Inc, Surface Solutions Group LLC, Aculon Inc, Formacoat LLC, Applied Medical Coatings LLC.

North America was the dominating region in the lubricious medical device coatings market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the lubricious medical device coatings market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lubricious medical device coatings market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.